Get Permission Abushal, Alsaiari, Nora, Gusti, and Nouri: Prevalence and determinants of public speaking anxiety in family medicine residents


Introduction

Public speech anxiety (PSA), or public-speaking phobia, is a specific entity of social anxiety disorders, or social phobia disorders,1 which are characterized by fear attitude and avoidance behaviors towards specific social situations, in anticipation of being negatively appraised or rejected by the others.2 Most cases of PSA cases are presumably benign, and frequently underdiagnosed or confounded within other symptoms of social phobia. However, it is estimated that one-third of PSA cases are distinctively occurring in speech situations and are classified as a distinct subtype of social anxiety disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).1, 3, 4, 5

Generally speaking, anxiety disorders represent the most common mental disorders,6 affecting one-third of the population at some point of their lives.7 They refer to excessive, anticipated fear that interferes with daily social relationships and professional performance of an individual, resulting in multidimensional impact on the quality of life and psychosocial wellbeing.8, 9, 10, 11 Likewise, PSA, among other social anxiety disorders, is associated with impaired psychosocial functioning, where the performance anxiety leads viciously to low social, occupational, and educational performance of the individual, self-depreciation, and social exclusion.4, 12, 13, 14

The other distinctive characteristic of PSA is the differential implication of the symptoms and their impact depending on the social and professional status and expectations of the individual. PSA symptoms may be more debilitating for individuals with occupations that rely particularly on public speech performance. A mixed-method study from Oman showed that PSA among college graduates was associated with low self-confidence and perceived academic skills, which impacted students’ aptitude to demonstrate their skills to their employer.15 Another study from Jizan, Saudi Arabia, demonstrated that undergraduate students with higher scores for social anxiety disorder underwent significant social and professional disability, and fear and avoidance of public speech was the most frequently reported situation of social phobia.16 Another remarkable feature of PSA is its association with foreign languages and the individual’s proficiency in the given language. A study involving English as Foreign Language (EFL) students in Saudi Arabia showed that up to 87% reported speech anxiety symptoms while speaking in English and the presence of PSA was negatively correlated with the student’s performance in the speaking test.17 Another Malaysian study among international postgraduate students showed that students with poor skills and competence in the English language were at higher risk of PSA compared with those who had good skills and competence.18

In the medical profession, literature lacks data on the prevalence or impact of PSA. Yet, medical trainees and professionals are exposed to several situations of audience speech as part of their training or professional and academic duties, such as case presentations and conference presentations, etc. Thus, besides being a good clinician, physicians need to master the art of public speaking to enhance their productivity in clinical, academic, and community-based activities. Previous evidence showed that interpersonal and communication skills among medical professionals are correlated with the patient’s health outcomes, as reduced communication skills are associated with greater risk or error.19 The researchers hypothesized that PSA is a disabling and underdiagnosed condition among medical residents, which would affect their clinical and communication skills and require recognition and corrective measures.

As such, the researchers designed this study to estimate the prevalence, to assess the severity, and to explore the determinants of PSA among family medicine trainees at the Joint Program of Family Medicine, Jeddah, Saudi Arabia, 2020.

Materials and Methods

Design and participants

This is a descriptive and analytical cross-sectional study carried out among all family medicine residents, at all educational levels, who were registered at the Joint Program of Family Medicine in Jeddah, Saudi Arabia, in 2020. The study protocol received ethical approval from both the director and the research committee of the Joint program of the Family Medicine of Jeddah.

Settings

The Joint Program of Family Medicine, Jeddah, includes three sectors, the Ministry of Health, King Fahad Armed Forces Hospital, and King Faisal Specialist Hospital and Research Center. The program included four levels of training, R1-R4. This program is approved by the Saudi Commission for health specialties, besides other programs of family medicine such as the National Guard Hospital and King Abdulaziz University Hospital.

Sampling

A total of 195 residents were available in the 2020 program. They were distributed across the levels as follows: level one (n= 42; females=22, males=20) level two (n=53; females=29, males=24) level three (n=52; females=31, males=21) level four (n=49; females=41, males=8).

By using the Raosoft sample size calculator program, the calculated sample size was 130 residents. The following parameters have been used to calculate the sample size: estimated margin error 5%, 95% confidence level, and the prevalence rate of PSA 50% (unknown). Ten percent of the calculated sample size was added to compensate for the defaulters. Therefore, the final sample size was 144 residents.

A stratified sampling technique was used to select 36 residents from each level. No stratification per gender was performed.

Data collection tool

Data was collected via a validated, self-administered questionnaire in the English language. The questionnaire comprised of three sections. Section one explored sociodemographic and academic factors which included age category, gender, residency level, previous negative experience with public speech, and family history of social anxiety. Section two consisted of the Personal Report of Public Speaking Anxiety (PRPSA) questionnaire, which is a 34-item scale developed by McCroskey, in 1970, for measuring fear of public speaking.20 Each of the 34 items is rated on a five-item Likert-type agreement scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Among the items, 22 enclose negative statements, such as “I feel anxious while waiting to give my speech”, while 12 items are positive statement, such as “I enjoy preparing for a speech”. The PRPSA score (range 34-170) was calculated as the sum of the item scores, and three PSA levels were defined including low (PRPSA score <98), moderate (PRPSA score 98-131), and high (PRPSA score>131). In the scoring system, the positively formulated items of PRPSA are reversed so that higher scores reflect higher levels PSA. The 34-item version of the PRPSA was shown to have an excellent internal consistency, with a Cronbach’s alpha 0.90-0.94.20, 21 Section three explored three specific situation s of public speech anxiety including difficulty presenting in English, in front of an audience from the opposite gender, and in front of an audience of higher educational level (3 items).

Data collection technique

The questionnaire was edited on Google Forms platform and distributed as a link that was disseminated by SMS to the mobile phone numbers of each participant.

Study variables

The dependent variable

The study outcome consisted of the level of PSA indicated by the PRPSA score, which was categorized into three levels: low (PRPSA score <98), moderate (PRPSA score 98-131), and high (PRPSA score >131).

The independent variables

Gender, age, residency training level, family history of social anxiety disorder, and previous negative experience while public speaking.

Statistical methods

Data was analyzed using SPSS, version 20 for Windows (IBM SPSS Statistics 20, IBM Corporation, Armonk, NY, USA, 2014). Descriptive statistics were used to present frequencies and percentages on categorical variables and means and standard deviations (SD) on continuous variables. Chi square was used to analyze the association between the levels of PSA and the explored sociodemographic and academic factors. Further, the effect of the resident’s gender on certain specific situations was analyzed using chi square test. A P-value < 0.05 was considered for significance.

Results

Characteristics of the study population

One hundred and thirty-one residents completed the questionnaire. Of these, 59.5% were female and 90.1% were aged 25-29 years. The distribution across residency level was quite fair 20-30% by level (Table 1).

Table 1

Characteristics of study population (N=131)

Variable

Frequency

Percentage

Age

Less than 25

1

0.8

25 to 29

118

90.1

30 to 34

11

8.4

More than 34

1

0.8

Total

131

100.0

Gender

Male

53

40.5

Female

78

59.5

Total

131

100.0

Residency Training Level

R1

26

19.8

R2

39

29.8

R3

26

19.8

R4

40

30.5

Total

131

100.0

Levels of PSA

The mean PRPSA was 100.27 out of 170 (SD = 18.10). Of the participants, 55.0% had moderate and 6.9% had high PRPSA scores (Table 2).

Table 2

Frequency distribution of personal report of public speaking anxiety

PRPSA Level (score)

Frequency

Percentage

Low (<98)

50

38.2

Moderate (98-131)

72

55.9

High (131)

9

6.9

[i] PRPSA: Personal Report of Public Speaking Anxiety

Factors associated with Personal Report of Public Speaking Anxiety

The levels of PSA were significantly associated with gender, residency level, previous negative experience with public speech, and family history of anxiety (Table 3). Female participants had a higher percentage of moderate (61.5% vs 45.3%) and high (9.0% vs 3.8%) PRPSA scores compared with males, respectively (p=0.041). R3 residents had the highest percentage of high PRPSA score (23.1%), followed by R1 (7.7%) and R2 (2.6%), while 0.0% of R4 displayed high PRPSA scores (p=0.020). A previous negative experience with public speech was also associated with a higher percentage of moderate (73.7% vs 47.3%) and high (15.8% vs 3.2%) PRPSA scores compared to absence of such an experience (p<0.001). Finally, participants with a family history of social anxiety had a higher risk of increased PRPSA (p=0.022).

Table 3

Factors associated with personal report of public speaking anxiety (N=131)

Level

Variable

Low

Moderate

High

Total

Statistics

p-value

%

%

Age (years)

n

n

<25

0

0.0

1

100.0

0

0.0%

1

0.8

5.167

0.683

25-29

44

37.3

66

55.9

8

6.8%

118

90.1

30-34

5

45.5

5

45.5

1

9.1%

11

8.4

>34

1

100.0

0

0.0

0

0.0%

1

0.8

Gender

Male

27

50.9

24

45.3

2

3.8%

53

40.5

6.337

0.041*

Female

23

29.5

48

61.5

7

9.0%

78

59.5

Residency level

R1

9

34.6

15

57.7

2

7.7%

26

19.8

13.838

0.020*

R2

13

33.3

25

64.1

1

2.6%

39

29.8

R3

8

30.8

12

46.2

6

23.1%

26

19.8

R4

20

50.0

20

50.0

0

0.0%

40

30.5

Previous negative experience with public speech

21.519

0.000*

Yes

4

10.5

28

73.7

6

15.8%

38

71.0

No

46

49.5

44

47.3

3

3.2%

93

29.0

Family history of social anxiety

Yes

4

21.1

12

63.2

3

15.8%

19

14.5

10.636

0.022*

No

39

47.6

40

48.8

2

2.4%

82

62.6

I don’t know

7

23.3

20

66.7

3

10.0%

30

22.9

Specific situations of public speech anxiety and the effect of gender

The prevalence of speech anxiety was remarkably high in the following situations: presenting in English (62.8%); presenting in front of an audience from the opposite gender (73.6%); and presenting in front of an audience of a higher educational level (84.6%). No statistically significant difference was observed between the two genders regarding these specific issues (p>0.05) (Table 4).

Table 4

Effect of gender on specific situations of public speech anxiety (N=131)

Situation

Total

Male

Female

Statistics

p-value

%

%

%

Difficulty presenting in English

Yes

76

62.8

26

59.1

50

64.9

No

45

37.2

18

40.9

27

35.1

0.409

0.522

Difficulty presenting in front of an audience from the opposite gender

Yes

92

73.6

37

77.1

55

71.4

No

33

26.4

11

22.9

22

28.6

0.0106

0.898

More anxiety presenting in front of an audience from a higher educational level

Yes

104

84.6

40

88.9

64

82.1

No

19

15.4

5

11.1

14

17.9

1.021

0.312

Discussion

Relevance and summary of findings

The significance of investigating PSA lies in its potential of harming the social life, academic, and professional careers of afflicted individuals, which may further impair their psychosocial well-being and have a significant social and economic impact at a larger scale. Estimating the prevalence and analyzing the determinants of PSA among medical residents enables appraising its burden on the medical profession and the relevance of implementing measures to prevent and tackle its consequences. This study showed that almost two-third of the family medicine residents experienced moderate or severe levels of PSA, with females being at higher risk than males. A previous negative experience with public speech as well as a family history of social anxiety was also significant factor for both moderate and severe PSA. The prevalence of anxiety was found to be higher in front of certain specific audience, notably that from the opposite gender or higher educational level.

Self-reported fear of speech

Most of the scales used to assess PSA are based on self-reported items related to cognitive, behavioral, and or psychological aspects of fear of speaking in public and avoidance behaviors. Among the other scales that are used to assess PSA are the Speech Anxiety Thoughts Inventory,22 the Self-Statements During Public Speaking,23 and the Public Speaking Anxiety Scale.24 The specificity of PRPSA design is that it is more appropriate in the educational context. A short version of the PRPSA, PRPSA-18, comprising of 18 items was found to be valid, reliable (Cronbach’s alpha = 0.96), and strongly correlated with the original version (correlation coefficient = 0.99). The PRPSA-18 version was found to have a bifactorial structure, and the two factors were termed “Anticipatory anxiety and physiological symptoms during speech performance” and “Lack of control during speech performance”.25 However, the original version of PRPSA was previously demonstrated to have a unifactorial structure by its developers,20 while another one found a six-factor structure.21 Analyzing the factorial structure of PRPSA was beyond the objectives of this study.

Levels of public speech anxiety

The researchers found high levels of PSA in the studied population of medical residents. By considering both moderate and high PRPSA scores, approximately, 62% of the study population would suffer PSA symptoms at different levels or circumstances. This represents more than twice as much as the prevalence reported in the general population, estimated between 15-30%.1 Other data among postgraduate medical students showed that 17% of the participants had symptoms indicative of PSA.26 This is significantly lower than the prevalence of PSA found in the present study. However, other studies reported findings that are similar to the present study. A study conducted at the University of Karachi showed that 33.3% and 41.0% of the participating male and female students reported moderately high anxiety of public speaking and 29% and 38% reported moderate fear, respectively.27 Another Brazilian study that included 1,124 undergraduate university students from different faculties found a prevalence of PSA as high as 53%, using the Self-Assessment Scale for Speaking in Public.28

The differences across studies may be explained by methodological issues, including the use of different assessment tools. However, regardless of the assessment tool and validity of the findings, PSA remains an underdiagnosed and underrecognized entity, and this represents another aspect of its importance. Afflicted individuals often develop adaptive strategies to cope up with anxious situations and are less likely to seek for specialist help. A Swedish study among university students established a strong correlation between PSA and social phobia, where the concerned students developed avoidance behaviors, sometime subtle, in anticipation of speaking situations, besides other dysfunctional strategies. Furthermore, authors observed that social phobia prompted 16% of the concerned student to use anxiolytic drugs and 16% to extensive rehearsal in anticipation of a public speech.29 Another Saudi study showed a high prevalence of avoidance behaviors among Saudi university students, as a result of social anxiety disorder.16

Specific situations of public speaking anxiety

Two specific situations related to the type of audience demonstrated to be associated with a particularly high prevalence (74%-85%) of fear of speaking, with no significant difference across gender. These included presenting in front of an audience from the opposite gender or an audience of a higher educational level. Several features of the audience have been observed to influence the levels of PSA, such as the audience size,30 behavior and responsiveness (neutral, positive, or hostile), 31 and cultural or gender composition.31 Furthermore, findings from the present study suggested that nearly 63% of the family medicine residents experienced anxiety when they have to present in the English language, with no significant difference between genders. The correlation of PSA with foreign language speaking is well-known and has been extensively addressed in the literature.17, 32, 33 Several authors present foreign language anxiety as a distinct entity of PSA, as it may be isolated and multifactorial.34 In the case of Saudi medical trainees, because the curriculum is in English language, English language anxiety may be associated with low English proficiency, which may have a great impact on the scientific learning and communication abilities of the student throughout the college years.35 A local study showed that difficulties in English among Saudi medical students were associated with higher scores of generalized anxiety disorders.36

Tackling public speaking anxiety in medical residents

The latency and high prevalence of PSA among family medicine residents highlights the relevance of incorporating curricula to enhance public speaking and communication skills among medical trainees. These curricula should adopt evidence-based approaches. Clinically wise, where it may be debatable to consider screening for PSA and establishing a clinical diagnosis, it would be helpful to screen for severe cases with debilitating symptoms impacting the social life and academic career. However, developing an evidence-based therapeutic approach requires the assessment of the levels of social phobia and PSA in the pre- and post-intervention times, at least in the research phase.

These approaches may use different psychotherapeutic strategies, combined with social learning and or educational strategies. Several therapeutic strategies based on different psychological theories have been developed and tested in PSA and social anxiety disorders. Examples of methods that showed satisfying results in reducing anxiety include cognitive and behavioral therapies,37 stress inoculation training,38 attention modification interventions,39 and hypnotherapy-based approaches.40 On the other hand, the researchers noted the recent emergence of internet-delivered therapies using either cognitive and behavioral therapy approaches or self-help programs.1 Among these methods is the use of online group exposure sessions, which showed significant improvement of PSA symptoms among afflicted university students, and the therapeutic effect persisted one year after the intervention.41 Other approaches were based on virtual reality environments. A systematic review including 13 controlled trials showed that exposure to public speech using virtually recreated situations and spaces had 77% efficacy in reducing PSA in students with diagnosis or symptoms of social anxiety disorders.42

Other interventions were based on educational approaches, delivering courses on the art of speaking. These approaches are based on the assumption that people are not born public speakers; but are trained to become one. In such approaches, nervousness and other psychosomatic symptoms occurring while delivering a public speech may be considered “physiological” at certain levels, and would disappear after adequate training. A pre-post-interventional study showed significant reduction in mean PRPSA score from 114.8 to 102.2 among 468 undergraduate university students after the completion of a standardized course on the basics of public speaking. Furthermore, researchers observed that the intervention efficacy was greater among females, who had higher levels of PSA in baseline.43 Such approaches, purely educational, may have the benefit of reducing the stigma and other eventual adverse effects that may result from a positive diagnosis of PSA of social anxiety disorder.

Other interventions used pharmacological approaches. A placebo-controlled trial by Bergamaschi et al. demonstrated the beneficial effect of pre-treatment with cannabidiol in reducing PSA and the resulting cognitive impairment.44 Such effect probably explains the association of social anxiety disorder with cannabis misuse.45 The same associations were observed with alcohol and other substance misuse,46, 47 which adds another weight on the burden of PSA in some specific populations and call for extreme caution in the promotion or use of certain derivative drugs.

Limitations

The present study failed to explore certain potential factors and confounders of PSA such as socioeconomic class, personal history of anxiety disorders, English proficiency, academic performance, and experience in conference presentation, etc. This, added to the methodological limitations such as the small sample size and internet-based assessment, may impact the generalizability of the findings.

Conclusion

Public speaking anxiety is an underdiagnosed and highly prevalent condition. Approximately two-third of the family medicine residents experience significant symptoms related to PSA, which may be debilitating for 7% of them. Female trainees as well as those with a family history of social anxiety disorder have higher risk of PSA. The latency and high prevalence of PSA among family medicine residents highlights the relevance of incorporating curricula to enhance public speaking and communication skills among medical trainees. More research and clinical studies are warranted to estimate the prevalence and analyze the determinants of PSA, and to determine evidence-based preventive and therapeutic approaches. The use of virtual reality and education-based methods may be particularly effective and cost-effective in the context of medical students and other concerned health professionals.

Source of Funding

None.

Conflict of Interest

None.

References

1 

CB Pull Current status of knowledge on public-speaking anxietyCurr Opin Psychiatry2012251328

2 

F Schneier J Goldmark D Stein B Vythilingum Social anxiety disorderAnxiety disorders and genderSpringer International PublishingCham20154967

3 

BF Grant DS Hasin C Blanco FS Stinson SP Chou RB Goldstein The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsJ Clin Psychiatry20056611135161

4 

MB Stein LJ Torgrud JR Walker Social phobia symptoms, subtypes, and severity: findings from a community surveyArch Gen Psychiatry20005711104652

5 

American Psychiatric Association, Others. Diagnostic and statistical manual of mental disorders: DSM-5. Washington: American Psychiatric Pub2013https://med-mu.com/wp-content/uploads/2018/08/American-Psychiatric-Association-Diagnostic-and-statistical-manual-of-mental-disorders-_-DSM-5-American-Psychiatric-Association-2013.pdf

6 

AJ Baxter T Vos KM Scott RE Norman AD Flaxman J Blore The regional distribution of anxiety disorders: implications for the Global Burden of Disease StudyInt J Methods Psychiatr Res201023442238

7 

B Bandelow S Michaelis Epidemiology of anxiety disorders in the 21st centuryDialogues Clin Neurosci201517332735

8 

JB Priest Anxiety disorders and the quality of relationships with friends, relatives, and romantic partnersJ Clin Psychol20136917888

9 

J Wald IZ Schultz ES Rogers Anxiety disorders and work performanceWork accommodation and retention in mental healthSpringerNew York201112140

10 

P Kasalova J Prasko M Holubova K Vrbova D Zmeskalova M Slepecky Anxiety disorders and marital satisfactionNeuro Endocrinol Lett201838855564

11 

SG Hofmann JQ Wu H Boettcher Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysisJ Consult Clin Psychol201482337591

12 

I Iancu E Bodner IZ Ben-Zion Self esteem, dependency, self-efficacy and self-criticism in social anxiety disorderCompr Psychiatry20155816571

13 

IM Aderka SG Hofmann A Nickerson H Hermesh E Gilboa-Schechtman S Marom Functional impairment in social anxiety disorderJ Anxiety Disord2012263393400

14 

S Daly Behavioural correlates of social anxietyBr J Soc Clin Psychol197817211720

15 

O Ibrahim S Devesh Implication of public speaking anxiety on the employability of Omani graduatesJ Teach Learn Grad Employab201910212235

16 

RM Hakami MS Mahfouz AM Adawi AJ Mahha AJ Athathi HH Daghreeri Social anxiety disorder and its impact in undergraduate students at Jazan University, Saudi ArabiaMent Illn2018927274

17 

HHA Al-Khotaba EHA Alkhataba S Abdul-Hamid B Ibrahim Foreign Language Speaking Anxiety: A Psycholinguistic Barrier Affecting Speaking Achievement of Saudi EFL LearnersArab World Engl J201910431329

18 

AA Gaibani Determining the role of English language competence in influencing the public speaking anxiety of international post graduate students at the University of Utara, MalaysiaInt J Learn Dev20144211120

19 

TW Reader R Flin BH Cuthbertson Communication skills and error in the intensive care unitCurr Opin Crit Care20071367326

20 

JC McCroskey Measures of communication-bound anxietySpeech Monogr19703742697710.1080/03637757009375677

21 

TC Hsu A study on the EFL students’ speech related anxiety in TaiwanInt J Res Stud Lang Learn201212318

22 

Y Cho JAJ Smits MJ Telch The speech anxiety thoughts inventory: scale development and preliminary psychometric dataBehav Res Ther20044211325

23 

SG Hofmann PM Dibartolo An instrument to assess self-statements during public speaking: scale development and preliminary psychometric propertiesBehav Ther2000313499515

24 

EM Bartholomay DD Houlihan Public speaking anxiety scale: preliminary psychometric data and scale validationPersonal Individual Differ2016942115

25 

E Mörtberg M Jansson-Fröjmark A Pettersson T Hennlid-Oredsson Psychometric properties of the personal report of public speaking anxiety (PRPSA) in a sample of university students in SwedenInt J Cogn Ther201811442133

26 

V Tejwani D Ha C Isada Observations: public speaking anxiety in graduate medical education-a matter of interpersonal and communication skills?J Grad Med Educ2016811111

27 

K Perveen Y Hasan AR Aleemi Glossophobia: The fear of public speaking in female and male students of University of KarachiPak J Gend Stud20181615770

28 

ACF Marinho AM deMedeiros EP Lima JJ Pantuza LC Teixeira Prevalence and factors associated with fear of public speakingCodas2019316e20180266

29 

M Tillfors T Furmark Social phobia in Swedish university students: prevalence, subgroups and avoidant behaviorSoc Psychiatry Psychiatr Epidemiol20074217986

30 

F Mostajeran MB Balci F Steinicke S Kuhn J Gallinat The effects of virtual audience size on social anxiety during public speakingIEEE Conference on Virtual Reality and 3D User Interfaces (VR)202030312

31 

M Chollet T Wörtwein LP Morency A Shapiro S Scherer Exploring feedback strategies to improve public speakingProceedings of the 2015 ACM International Joint Conference on Pervasive and Ubiquitous Computing - UbiComp 152015ACM PressNew York, USA114354

32 

EK Horwitz M Tallon H Luo Anxiety in schools: The causes, consequences, and solutions for academic anxietiesPeter Lang2010296115

33 

T Al-Saraj Foreign language anxiety: what is it?4th Bloomsbury student conference in applied linguistics2011Birkbeck College, University of LondonBirkbeck College, UK

34 

R Hanifa Factors generating anxiety when learning EFL speaking skillsStud Engl Lang Educ2018522309

35 

F Kaliyadan N Thalamkandathil SR Parupalli TT Amin MH Balaha WHAB Ali English language proficiency and academic performance: A study of a medical preparatory year program in Saudi ArabiaAvicenna J Med201505041404

36 

A Alatawi A Alghamdi A Albalwi M Altayar M Jalal EA Frah Prevalence of generalized anxiety disorder (gad) among Saudi medical students and associated risk factorsInt J Med Res Health Sci2020519

37 

P Cuijpers I A Cristea E Karyotaki M Reijnders Mjh Huibers How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidenceWorld Psychiatry201615324558

38 

B Jackson J Compton AL Thornton JA Dimmock Re-thinking anxiety: using inoculation messages to reduce and reinterpret public speaking fearsPLoS One2017121e0169972

39 

RJ Mcnally PM Enock C Tsai M Tousian Attention bias modification for reducing speech anxietyBehav Res Ther201351128828

40 

KE Valentine LS Milling LJ Clark CL Moriarty The efficacy of hypnosis as a treatment for anxiety: a meta-analysisInt J Clin Exp Hypn201967333663

41 

M Tillfors P Carlbring T Furmark S Lewenhaupt M Spak A Eriksson Treating university students with social phobia and public speaking fears: internet delivered self-help with or without live group exposure sessionsDepress Anxiety200825870817

42 

FJ Hinojo-Lucena I Aznar-Díaz MP Cáceres-Reche JM Trujillo-Torres JM Romero-Rodríguez Virtual reality treatment for public speaking anxiety in students. advancements and results in personalized medicineJ Pers Med202010114

43 

KM Hunter JN Westwick LL Haleta Assessing Success: The Impacts of a Fundamentals of Speech Course on Decreasing Public Speaking AnxietyCommun Educ201463212435

44 

MM Bergamaschi RHC Queiroz MHN Chagas DCG deOliveira BS De Martinis F Kapczinski Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patientsNeuropsychopharmacology2011366121926

45 

JD Buckner NB Schmidt L Bobadilla J Taylor Social anxiety and problematic cannabis use: Evaluating the moderating role of stress reactivity and perceived copingBehav Res Ther2006447100715

46 

S Stevens B Cludius T Bantin C Hermann AL Gerlach Influence of alcohol on social anxiety: An investigation of attentional, physiological and behavioral effectsBiol Psychol20149612633

47 

JD Buckner PE Morris CN Abarno NI Glover EM Lewis Biopsychosocial model social anxiety and substance use revisedCurr Psychiatry Rep202123635



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 17-09-2022

Accepted : 20-09-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jchm.2022.035


Article Metrics






Article Access statistics

Viewed: 794

PDF Downloaded: 370



Medical Abbreviation List